207 related articles for article (PubMed ID: 29074453)
21. Whole-exome Sequencing Reveals New Potential Susceptibility Genes for Japanese Familial Pancreatic Cancer.
Takai E; Nakamura H; Chiku S; Kubo E; Ohmoto A; Totoki Y; Shibata T; Higuchi R; Yamamoto M; Furuse J; Shimizu K; Takahashi H; Morizane C; Furukawa T; Yachida S
Ann Surg; 2022 Apr; 275(4):e652-e658. PubMed ID: 32826389
[TBL] [Abstract][Full Text] [Related]
22. Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.
Van Marcke C; Helaers R; De Leener A; Merhi A; Schoonjans CA; Ambroise J; Galant C; Delrée P; Rothé F; Bar I; Khoury E; Brouillard P; Canon JL; Vuylsteke P; Machiels JP; Berlière M; Limaye N; Vikkula M; Duhoux FP
Breast Cancer Res; 2020 Apr; 22(1):36. PubMed ID: 32295625
[TBL] [Abstract][Full Text] [Related]
23. Whole genome sequencing identifies rare germline variants enriched in cancer related genes in first degree relatives of familial pancreatic cancer patients.
Tan M; Brusgaard K; Gerdes AM; Mortensen MB; Detlefsen S; Schaffalitzky de Muckadell OB; Joergensen MT
Clin Genet; 2021 Nov; 100(5):551-562. PubMed ID: 34313325
[TBL] [Abstract][Full Text] [Related]
24. Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer.
Roberts NJ; Norris AL; Petersen GM; Bondy ML; Brand R; Gallinger S; Kurtz RC; Olson SH; Rustgi AK; Schwartz AG; Stoffel E; Syngal S; Zogopoulos G; Ali SZ; Axilbund J; Chaffee KG; Chen YC; Cote ML; Childs EJ; Douville C; Goes FS; Herman JM; Iacobuzio-Donahue C; Kramer M; Makohon-Moore A; McCombie RW; McMahon KW; Niknafs N; Parla J; Pirooznia M; Potash JB; Rhim AD; Smith AL; Wang Y; Wolfgang CL; Wood LD; Zandi PP; Goggins M; Karchin R; Eshleman JR; Papadopoulos N; Kinzler KW; Vogelstein B; Hruban RH; Klein AP
Cancer Discov; 2016 Feb; 6(2):166-75. PubMed ID: 26658419
[TBL] [Abstract][Full Text] [Related]
25. Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals.
;
Am J Hum Genet; 2019 Aug; 105(2):267-282. PubMed ID: 31327507
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous preterm birth: advances toward the discovery of genetic predisposition.
Strauss JF; Romero R; Gomez-Lopez N; Haymond-Thornburg H; Modi BP; Teves ME; Pearson LN; York TP; Schenkein HA
Am J Obstet Gynecol; 2018 Mar; 218(3):294-314.e2. PubMed ID: 29248470
[TBL] [Abstract][Full Text] [Related]
27. Calibrated rare variant genetic risk scores for complex disease prediction using large exome sequence repositories.
Lali R; Chong M; Omidi A; Mohammadi-Shemirani P; Le A; Cui E; Paré G
Nat Commun; 2021 Oct; 12(1):5852. PubMed ID: 34615865
[TBL] [Abstract][Full Text] [Related]
28. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
[TBL] [Abstract][Full Text] [Related]
29. Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension.
Zhu N; Pauciulo MW; Welch CL; Lutz KA; Coleman AW; Gonzaga-Jauregui C; Wang J; Grimes JM; Martin LJ; He H; ; Shen Y; Chung WK; Nichols WC
Genome Med; 2019 Nov; 11(1):69. PubMed ID: 31727138
[TBL] [Abstract][Full Text] [Related]
30. Whole-exome sequencing of pancreatic neoplasms with acinar differentiation.
Jiao Y; Yonescu R; Offerhaus GJ; Klimstra DS; Maitra A; Eshleman JR; Herman JG; Poh W; Pelosof L; Wolfgang CL; Vogelstein B; Kinzler KW; Hruban RH; Papadopoulos N; Wood LD
J Pathol; 2014 Mar; 232(4):428-35. PubMed ID: 24293293
[TBL] [Abstract][Full Text] [Related]
31. Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study.
Childs EJ; Chaffee KG; Gallinger S; Syngal S; Schwartz AG; Cote ML; Bondy ML; Hruban RH; Chanock SJ; Hoover RN; Fuchs CS; Rider DN; Amundadottir LT; Stolzenberg-Solomon R; Wolpin BM; Risch HA; Goggins MG; Petersen GM; Klein AP
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1185-91. PubMed ID: 27197284
[TBL] [Abstract][Full Text] [Related]
32. Family specific genetic predisposition to breast cancer: results from Tunisian whole exome sequenced breast cancer cases.
Hamdi Y; Boujemaa M; Ben Rekaya M; Ben Hamda C; Mighri N; El Benna H; Mejri N; Labidi S; Daoud N; Naouali C; Messaoud O; Chargui M; Ghedira K; Boubaker MS; Mrad R; Boussen H; Abdelhak S;
J Transl Med; 2018 Jun; 16(1):158. PubMed ID: 29879995
[TBL] [Abstract][Full Text] [Related]
33. Rare, Pathogenic Germline Variants in
Esai Selvan M; Klein RJ; Gümüş ZH
Clin Cancer Res; 2019 Mar; 25(5):1517-1525. PubMed ID: 30425093
[TBL] [Abstract][Full Text] [Related]
34. Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic
Alenezi WM; Fierheller CT; Revil T; Serruya C; Mes-Masson AM; Foulkes WD; Provencher D; El Haffaf Z; Ragoussis J; Tonin PN
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456503
[TBL] [Abstract][Full Text] [Related]
35. Loss-of-Function Variants in the Tumor-Suppressor Gene
Olafsdottir T; Stacey SN; Sveinbjornsson G; Thorleifsson G; Norland K; Sigurgeirsson B; Thorisdottir K; Kristjansson AK; Tryggvadottir L; Sarin KY; Benediktsson R; Jonasson JG; Sigurdsson A; Jonasdottir A; Kristmundsdottir S; Jonsson H; Gylfason A; Oddsson A; Fridriksdottir R; Gudjonsson SA; Zink F; Lund SH; Rognvaldsson S; Melsted P; Steinthorsdottir V; Gudmundsson J; Mikaelsdottir E; Olason PI; Stefansdottir L; Eggertsson HP; Halldorsson BV; Thorsteinsdottir U; Agustsson TT; Olafsson K; Olafsson JH; Sulem P; Rafnar T; Gudbjartsson DF; Stefansson K
Cancer Res; 2021 Apr; 81(8):1954-1964. PubMed ID: 33602785
[TBL] [Abstract][Full Text] [Related]
36. Population-based identity-by-descent mapping combined with exome sequencing to detect rare risk variants for schizophrenia.
Harold D; Connolly S; Riley BP; Kendler KS; McCarthy SE; McCombie WR; Richards A; Owen MJ; O'Donovan MC; Walters J; ; ; Donohoe G; Gill M; Corvin A; Morris DW
Am J Med Genet B Neuropsychiatr Genet; 2019 Apr; 180(3):223-231. PubMed ID: 30801977
[TBL] [Abstract][Full Text] [Related]
37. AGA Clinical Practice Update on Colorectal and Pancreatic Cancer Risk and Screening in BRCA1 and BRCA2 Carriers: Commentary.
Kupfer SS; Gupta S; Weitzel JN; Samadder J
Gastroenterology; 2020 Aug; 159(2):760-764. PubMed ID: 32335146
[No Abstract] [Full Text] [Related]
38. Genetic characterization of pancreatic cancer patients and prediction of carrier status of germline pathogenic variants in cancer-predisposing genes.
Mizukami K; Iwasaki Y; Kawakami E; Hirata M; Kamatani Y; Matsuda K; Endo M; Sugano K; Yoshida T; Murakami Y; Nakagawa H; Spurdle AB; Momozawa Y
EBioMedicine; 2020 Oct; 60():103033. PubMed ID: 32980694
[TBL] [Abstract][Full Text] [Related]
39. Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer.
Liu Y; Lusk CM; Cho MH; Silverman EK; Qiao D; Zhang R; Scheurer ME; Kheradmand F; Wheeler DA; Tsavachidis S; Armstrong G; Zhu D; Wistuba II; Chow CB; Behrens C; Pikielny CW; Neslund-Dudas C; Pinney SM; Anderson M; Kupert E; Bailey-Wilson J; Gaba C; Mandal D; You M; de Andrade M; Yang P; Field JK; Liloglou T; Davies M; Lissowska J; Swiatkowska B; Zaridze D; Mukeriya A; Janout V; Holcatova I; Mates D; Milosavljevic S; Scelo G; Brennan P; McKay J; Liu G; Hung RJ; Christiani DC; Schwartz AG; Amos CI; Spitz MR
J Thorac Oncol; 2018 Oct; 13(10):1483-1495. PubMed ID: 29981437
[TBL] [Abstract][Full Text] [Related]
40. Monogenic and polygenic determinants of sarcoma risk: an international genetic study.
Ballinger ML; Goode DL; Ray-Coquard I; James PA; Mitchell G; Niedermayr E; Puri A; Schiffman JD; Dite GS; Cipponi A; Maki RG; Brohl AS; Myklebost O; Stratford EW; Lorenz S; Ahn SM; Ahn JH; Kim JE; Shanley S; Beshay V; Randall RL; Judson I; Seddon B; Campbell IG; Young MA; Sarin R; Blay JY; O'Donoghue SI; Thomas DM;
Lancet Oncol; 2016 Sep; 17(9):1261-71. PubMed ID: 27498913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
